Reactive oxygen/nitrogen species contribute substantially to the antileukemia effect of APO866, a NAD lowering agent

APO866 is a small molecule drug that specifically inhibits nicotinamide phosphoribosyltransferase (NAMPT), a key enzyme involved in nicotinamide adenine dinucleotide (NAD) biosynthesis from the natural precursor nicotinamide. Although, the antitumor activity of APO866 on various types of cancer mode...

Descripción completa

Detalles Bibliográficos
Autores principales: Cloux, Anne-Julie, Aubry, Dominique, Heulot, Mathieu, Widmann, Christian, ElMokh, Oussama, Piacente, Francesco, Cea, Michele, Nencioni, Alessio, Bellotti, Axel, Bouzourène, Karima, Pellegrin, Maxime, Mazzolai, Lucia, Duchosal, Michel A., Nahimana, Aimable
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Impact Journals LLC 2019
Materias:
Research Paper
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6877101/
https://www.ncbi.nlm.nih.gov/pubmed/31803365
http://dx.doi.org/10.18632/oncotarget.27336

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6877101/
https://www.ncbi.nlm.nih.gov/pubmed/31803365
http://dx.doi.org/10.18632/oncotarget.27336

Ejemplares similares